BACKGROUND: The most common factor associated with poor control of hypertension is treatment nonadherence to antihypertensive drug therapy. OBJECTIVE: To measure drug nonadherence and associated factors in pharmacologically treated hypertensive patients. METHODS: A prospective observational study was carried out from March 2007 to August 2009 at a community pharmacy in Spain. A pharmacist invited a convenience sample of hypertensive patients aged 50 years and older taking antihypertensive medication for at least 3 months prior to participate in the study. Drug nonadherence was analyzed by 3 separate methods: pill count, as the gold standard method, and Haynes-Sackett and Morisky-Green questionnaires. A descriptive analysis of drug...
Hypertension is a global illness and one that affects circa 20% of the population. Despite the effe...
Objective: Medication nonadherence is a major cause of uncontrolled hypertension, but clinicians are...
The quality of assessment of non-adherence to treatment in hypertensive is poor. Within this review,...
Nonadherence is a common reason for treatment failure and treatment resistance. No matter how it is ...
Nonadherence to drugs is a challenge in hypertension treatment. We aimed to assess the prevalence of...
Nonadherence to drugs is a challenge in hypertension treatment. We aimed to assess the prevalence of...
ABSTRACT: Medication nonadherence represents a modifiable risk factor for patients with hypertension...
Nonadherence to drugs is a challenge in hypertension treatment. We aimed to assess the prevalence of...
The quality of assessment of non-adherence to treatment in hypertensive is poor. Within this review,...
AbstractBackgroundNonadherence to antihypertensive medicines limits their effectiveness, increases t...
Nonadherence to drugs is a challenge in hypertension treatment. We aimed to assess the prevalence of...
OBJECTIVE: Nonadherence to medication is present in at least 50% of patients with apparent treatment...
Nonadherence to drugs is a challenge in hypertension treatment. We aimed to assess the prevalence of...
OBJECTIVE Nonadherence to medication is present in at least 50% of patients with apparent treatme...
OBJECTIVE Nonadherence to medication is present in at least 50% of patients with apparent treatme...
Hypertension is a global illness and one that affects circa 20% of the population. Despite the effe...
Objective: Medication nonadherence is a major cause of uncontrolled hypertension, but clinicians are...
The quality of assessment of non-adherence to treatment in hypertensive is poor. Within this review,...
Nonadherence is a common reason for treatment failure and treatment resistance. No matter how it is ...
Nonadherence to drugs is a challenge in hypertension treatment. We aimed to assess the prevalence of...
Nonadherence to drugs is a challenge in hypertension treatment. We aimed to assess the prevalence of...
ABSTRACT: Medication nonadherence represents a modifiable risk factor for patients with hypertension...
Nonadherence to drugs is a challenge in hypertension treatment. We aimed to assess the prevalence of...
The quality of assessment of non-adherence to treatment in hypertensive is poor. Within this review,...
AbstractBackgroundNonadherence to antihypertensive medicines limits their effectiveness, increases t...
Nonadherence to drugs is a challenge in hypertension treatment. We aimed to assess the prevalence of...
OBJECTIVE: Nonadherence to medication is present in at least 50% of patients with apparent treatment...
Nonadherence to drugs is a challenge in hypertension treatment. We aimed to assess the prevalence of...
OBJECTIVE Nonadherence to medication is present in at least 50% of patients with apparent treatme...
OBJECTIVE Nonadherence to medication is present in at least 50% of patients with apparent treatme...
Hypertension is a global illness and one that affects circa 20% of the population. Despite the effe...
Objective: Medication nonadherence is a major cause of uncontrolled hypertension, but clinicians are...
The quality of assessment of non-adherence to treatment in hypertensive is poor. Within this review,...